Viewing Study NCT02020551


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-02-20 @ 12:35 PM
Study NCT ID: NCT02020551
Status: COMPLETED
Last Update Posted: 2013-12-25
First Post: 2013-12-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Lidocaine 10% Spray Reduces Pain During Intrauterine Device Insertion
Sponsor: Kayseri Education and Research Hospital
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2013-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Pain during intrauterine device (IUD) insertion can be a barrier to initiation. Misoprostol and nonsteroidal drugs have found to be ineffective by clinical trials.Investigators tested whether intracervical 2% lidocaine gel decreased insertion pain compared to placebo.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: